3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
13
Recruiting
5
Unknown
4
Withdrawn
2
Terminated
2
Active not recruiting
2
Not yet recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Conditions
Neoplasms
13
Carcinoma, Non-Small-Cell Lung
7
Breast Neoplasms
5
Prostatic Neoplasms
4
Neoplasm Metastasis
3
Melanoma
3
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Pancreatic Neoplasms
2
Neoplastic Cells, Circulating
2
Multiple Myeloma
2
Lung Neoplasms
2
Liver Neoplasms
2
Glioblastoma
2
Fibrosis
2
Colorectal Neoplasms
2
Cachexia
2
Vascular Malformations
1
Uterine Cervical Neoplasms
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Renal Insufficiency, Chronic
1
Recurrence
1
Pneumonia
1
Ovarian Neoplasms
1
Ovarian Cysts
1
Osteosarcoma
1
Obesity
1
Interventions
Blood Specimen Collection
2
Trastuzumab
1
Denosumab
1
Data Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Neoplastic Cells, Circulating
×
Blood Specimen Collection
×
Clear all
NCT05437679
2023-09-05
CHARTER
Angle plc
Terminated
9 enrolled
NCT01658332
2015-07-30
CIRCUBRONCH
Central Hospital, Nancy, France
Phase NA
Terminated
59 enrolled